Gastric Cancer
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 21, 2008; 14(19): 3006-3014
Published online May 21, 2008. doi: 10.3748/wjg.14.3006
Figure 8
Figure 8 The cell cycle analysis by FCM. A: SGC790 cells, the cell proportions of G0/G1 and S stages were 43.2% ± 1.2% and 47.7% ± 1.1% in the SGC7901cell without transfection, respectively; B: pSilencer3.1-H1/SGC7901 cells, the cell proportions of G0/G1 and S stages were 40.3% ± 2.0% and 49.3% ± 0.9% in the SGC7901 cell with the plasmid DNA of pSilencer3.1-H1 respectively; C: pSilencer3.1-shRNA/RUNX3SGC7901 cells, the cell proportions of G0/G1 and S stages were 37.2% ± 1.9% and 60.5% ± 0.8% in the SGC790 cells transfected with the recombinated plasmid-pSilencer3.1-H1-shRNA/RUNX3 respectively. Compared with that of G0/G1 and S stages of two controls, the cell proportions of G0/G1 and S stages in the pSilencer3.1-H1-shRNA/RUNX3/SGC7901 cells decreased and increased obviously, respectively (P < 0.05).